ArticleInternational journal of immunopathology and pharmacology

Rapamycin as a potent and selective inhibitor of vascular endothelial growth factor receptor in breast carcinoma.

Muhammad Shahidan Muhammad Sakri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.